Inflammatory bowel diseases (IBDs), i.e., Crohn's disease (CD) and ulcerative colitis (UC), are characterized by chronic relapsing inflammatory disorders of the gastrointestinal tract, impairing quality of life. [1] [2] [3] [4] [5] Although the etiology of IBDs still remains unclear, nationwide epidemiologic studies have clarified that the geographic incidence varies substantially, with higher rates in Northern and Western Europe, and Northern America than in Central and Southern Europe and many developing countries.
Inflammatory bowel diseases (IBDs), i.e., Crohn's disease (CD) and ulcerative colitis (UC), are characterized by chronic relapsing inflammatory disorders of the gastrointestinal tract, impairing quality of life. [1] [2] [3] [4] [5] Although the etiology of IBDs still remains unclear, nationwide epidemiologic studies have clarified that the geographic incidence varies substantially, with higher rates in Northern and Western Europe, and Northern America than in Central and Southern Europe and many developing countries. [2] [3] [4] [5] Epidemiologic and linkage studies strongly suggested the importance of a genetic factor for susceptibility to IBDs, but a genome-wide screening has identified a number of candidate loci, indicating the complexity of IBDs. 6) Among candidates, recent attention has focused on the gene MDR1/ABCB1 and its product, multidrug resistant transporter MDR1/P-glycoprotein, which is a glycosylated membrane protein of 170 kDa, belonging to the ATP-binding cassette superfamily of membrane transporters, [7] [8] [9] [10] [11] [12] as a consequence of several non-clinical and clinical investigations as summarized below. In 1998, Panwala et al. reported that mdr1a-/-knock-out mice were susceptible to a spontaneous UC-like intestinal inflammation under specific pathogen-free conditions. 13) Since mdr1a-/-knock-out mice are immunologically normal, the development of spontaneous colitis is presumably due to a defect in the barrier function of the intestinal epithelium. They also indicated that infection with Helicobacter bilis induced diarrhea, weight loss, and IBDs in mdr1a-/-knockout mice. [14] [15] [16] Macroscopic, microscopic and biochemical examinations have confirmed that the colitis which develops in this model is similar to that of human IBDs, [14] [15] [16] [17] and very recently, it has been confirmed that MDR1 mRNA expression in colonic tissues is down-regulated in patients with UC, but not with CD. 18) Next, MDR1 is located on chromosome 7 at q21.1, 19) which was one of the loci of susceptibility to
IBDs identified by a genome-wide analysis in an UK cohort, 6) and the linkage in this region has recently been confirmed by genome scan meta-analysis. 20) Finally, in 2003-2005, independent groups in Germany and Scotland indicated that a silent genetic polymorphism in exon 26, C3435T, is associated with susceptibility to UC, but not to CD, 21, 22) though the results are disputed. [23] [24] [25] [26] In the present study, the MDR1 polymorphisms of T-129C in the promoter region, a silent C1236T in exon 12, G2677A, T in exon 21, resulting in Ala893Thr and Ala893Ser, respectively, and C3435T were examined in 66 Japanese UC patients and 173 healthy subjects, and their value for predicting UC was analyzed independently. The effects of the G2677T/C3435T haplotype proposed by Johne et al. were also evaluated, 27) as well as those of the haplotype assigned by 4 polymorphisms. Here, the patients were stratified into 2 subpopulations based on age at onset; early onset patients and later onset patients, since epidemiologic investigations indicated that there might be more than 2 peaks in the age-related rates of incidence or prevalence, [2] [3] [4] [5] suggesting that the UC in the patients afflicted from a younger age might be different from that of later onset patients. The expression levels of MDR1 mRNA were also examined in rectal mucosa obtained from 17 UC patients and 16 healthy subjects, in order to explain the association of genotypes with susceptibility to UC.
MATERIALS AND METHODS
Subjects Sixty-six Japanese UC patients (37 males/29 females) with proctitis (nϭ14), left-sided colitis (nϭ27) and panclitis/entensive clitis (nϭ25) diagnosed based on clinical, endoscopic, radiological and histopathologic findings and treated with standard therapy in 1992-2004, were enrolled in this study. 28) Genomic DNA was isolated from whole blood using a QIAamp DNA Blood Kit (QIAGEN, Hilden, Germany) according to the manufacturer's directions. The PCR primers and TaqMan ® MGB probes for T-129C, G2677A, T and C3435T were reported previously. 28) As for C1236T, the following TaqMan ® MGB probe and primers were designed using a software, Assaysby-Design TM (Applied Biosystems Japan, Tokyo, Japan): the C The MDR1 G2677T/C3435T haplotypes and genotypes were assigned according to the report of Johne et al., 27) which takes no account of the A 2677 -allele, but is often used for assessing the significance of haplotype analyses. [7] [8] [9] [10] [11] [12] Additionally, the MDR1 haplotype were statistically inferred using an algorithm based on Bayesian inference, PHASE version 2.0.2 (http://www.stat.Washington.edu/stephens/). 29, 30) In the PHASE analysis, after an initial guess of haplotype pairs, Gibbs sampling, a type of Markov chain-Monte Carlo (MCMC) algorithm, was used to obtain an approximate sample from the posterior distribution of haplotype pairs given corresponding genotypes, and the haplotype reconstruction was given by repeating this process. 30) The details of theoretical background are presented in the literature. 30) Haplotypes were inferred by running PHASE a total of 10 times. The estimated haplotype frequencies were expressed as the average population haplotype frequencies for the whole sample (referred as "Population haplotype") as well as the practical haplotype frequencies based on the most likely inferred pairs of haplotypes identified at least 8 of 10 times for each individual (referred as "Practical haplotype").
Expression Levels of MDR1 mRNA in Rectal Mucosa Rectal mucosa was obtained by endoscope from 9 early onset patients, 8 later onset patients and 16 healthy subjects. The expression levels of MDR1 mRNA were measured using the real time quantitative RT-PCR method as described previously. [31] [32] [33] Total RNA was extracted from rectal mucosa using the RNeasy Mini Kit and the RNase-Free DNase Set (QIAGEN) according to the manufacturer's instructions. In each run of the assay, the mRNA levels of MDR1 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were measured and the mRNA level of MDR1 was expressed relative to that of GAPDH. Statistical Analysis All values are the meansϮS.D. Fisher's exact test was used to examine differences in genotype and allele frequencies between the groups. The expression levels of MDR1 mRNA were analyzed by multiple comparisons with ANOVA followed by the Scheffe test, or by the unpaired Student's t-test for pairs. p values less than 0.05 were considered significant. Table 1 lists the genotype and allelic frequencies of MDR1 T-129C, C1236T, G2677A, T and C3435T in 66 UC patients and 173 healthy subjects. No association of T-129C, C1236T or G2677A, T with susceptibility to UC was found, whereas C3435T was associated with UC, that is, the frequency of the T 3435 -allele was significantly higher in UC patients than healthy subjects (pϭ0.048), albeit with insufficient statistical power in the genotype ( pϭ0.108). In the later onset patients, C3435T was a strong predictor of susceptibility ( pϭ0.020 and 0.012 for genotype and allele, respectively), but no such effects were observed for the early onset patients. Table 2 lists the haplotype and genotype frequencies of MDR1 G2677T/C3435T in the UC patients and healthy subjects, which are assigned according to Johne et al. 27) This method takes no account of the A 2677 -allele, but 57/173 (32.9%) of healthy subjects and 17/66 (25.8%) of UC patients were carriers, a slight difference. It was found that genotype 22 was more frequent in the later onset patients than healthy subjects ( pϭ0.018), but no significant difference was detected between the early onset patients and healthy subjects (pϭ0.884). The haplotype frequencies based on MDR1 T-129C, C1236T, G2677A, T and C3435T are listed in Table 3 -C 3435 was hardly found in UC patients (0.9%) than healthy subjects (4.9%).
RESULTS
As shown in Table 4 , there was no significant difference in the level of MDR1 mRNA (/GAPDH mRNA) between the UC patients and healthy subjects (5.53Ϯ4.96 vs. 5.13Ϯ2.71, respectively). The level of expression in the early onset patients was similar to that in the later onset patients (5.08Ϯ2.63 vs. 4.34Ϯ2.73, respectively). The genotypes of MDR1 T-129C, C1236T, G2677A, T and C3435T had no effect on the mRNA expression in healthy subjects, but in the case of early onset patients, C3435T was found to result in higher level of expression (Fig. 1), 
DISCUSSION
MDR1 was originally isolated from resistant tumor cells as part of the mechanism of multidrug resistance, but over the last decade, it has been elucidated that human MDR1 is also expressed throughout the body, including the liver, kidneys, small and large intestines and brain, and confers intrinsic resistance to normal tissues and/or homeostasis to the entire body by exporting unnecessary or toxic exogenous substances. [7] [8] [9] [10] [11] [12] For example, intestinal P-glycoprotein located in the brush border membrane of enterocytes limits the absorption of substrates, and MDR1 and other transporters are recognized as an important class of proteins for regulating pharmacokinetics after oral administration. The first investigation of the effects of MDR1 genotypes on pharmacotherapy was reported in 2000. [7] [8] [9] [10] [11] [12] A silent C3435T was found to be associated with the duodenal expression of MDR1, and thereby the plasma concentration of digoxin after oral admin- -allele). Genotype coding is as follows; 0: homozygous for nucleotides identical to the reference sequence for the position at both chromosomes; 1: heterozygous; 2: homozygous for nucleotides different from the reference sequence for the position at both chromosomes. 27) For genotype 11, 2 haplotype pairs (11/22 and 12/21) are possible, but 11/22 is selected based on the frequency in Caucasians. b) Fisher's exact test (extended) was applied for the comparison of groups after exclusion of Aistration. In the last 5 years, clinical studies have been conducted around the world; however, there are still discrepancies in the results. [7] [8] [9] [10] [11] [12] Since potential roles for MDR1 in detoxification systems of normal tissues have been suggested by non-clinical and clinical investigations, additional studies on MDR1 genotypes have been conducted in terms of susceptibility to a certain class of diseases, especially in cases where a MDR1-related etiology is demonstrated. In 2003, Schwab et al. indicated a significantly increased frequency of the T-allele at position 3435 in patients with UC, not with CD, in a case-control study with unrelated German Caucasians. 21) Meanwhile, Brant et al. found no effects of C3435T on susceptibility to both using a pedigree-based transmission/disequilibrium test, but they indicated an association of G2677T with CD, but not with UC. 23) Immediately after, Croucher et al. tried to reproduce the findings of Schwab et al. in two well established and independent northern European cohorts, however they failed to detect the effects of C3435T. 24) There was no ethnic information on the subjects in the analysis by Croucher et al., indicating the necessity for further investigations, since ethnicity definitely affects the frequency. [7] [8] [9] [10] [11] [12] In 2004, two additional brief reports on C3435T were presented by Glas et al. 25) and Gazouli et al., 26) where the ethnicity of the participants was well-controlled, but their results were still inconsistent with, or only partially consistent with, the findings of Schwab et al. In contrast, very recently, Ho et al. concluded that C3435T is a risk factor for UC in a large, independent, well-characterized population of white Scottish subjects. 22) As summarized above, there are the discrepancies in the results on C3435T, and therefore this study was conducted to find out why. Here, we have focused on the age of onset based on epidemiological investigations. Björnsson et al. clearly indicated 2 peaks in the age-related incidence of both IBDs in a study conducted in Iceland. 3, 4) Bernstein et al. also suggested 2 peaks in the incidence of UC, but not of CD, in a population-based study in Canada, 5) suggesting that the UC in the patients afflicted from a younger age might be different from that of later onset patients. Although the existence of multiple peaks remains controversial, 2) as shown in Table 1 , it has been suggested herein that C3435T is a strong risk factor for later onset UC, whereas no effects are found for early onset UC. Very recently, the age-dependent association of 
C3435T has also found for colon cancer. 34) It is somewhat strange that the genetic factor is associated with later onset UC, rather than early onset UC. The data suggests that a person with T 3435 -allele is susceptible to UC than others, but it will take much time to onset, and MDR1 is not associated with early onset UC. Consequently, it was suggested that the discrepancies in the previous reports might be, in part, due to the difference in the age of onset of the patients analyzed.
C3435T is in linkage disequilibrium with C1236T or G2677T, [7] [8] [9] [10] [11] [12] and Ho et al. have suggested that the two-locus haplotype of G2677T and C3435T might be predictive of susceptibility. 22) Johne et al. have defined 4 haplotypes and 9 genotypes based on G2677T and C3435T. 27) Despite that no account is taken of the A 2677 -allelle, this assignment is often used to check the importance of haplotype analyses for the establishment of personalized medicine. [7] [8] [9] [10] [11] [12] Recently, an extensive screening of genetic polymorphisms was performed by Kroetz et al., 29) resulting in the definition of 32 haplotypes (MDR1*1 to MDR1*32) and their subtypes (a total of 64 haplotypes). Although these assignments should be justified by genotype-phenotype correlation studies, Johne's assignment was applied herein to clarify the importance of the haplotype analysis. As shown in Tables 1 and 2 , it is concluded that analyzing the G2677T/C3435T haplotype provides no advantage in terms of prediction, when compared with the stratification based only on C3435T. The variant A 2677 -allele is preferentially found in Asians, and has been shown to be important for the pharmacokinetics of the H 1 -antihistamine fexofenadine. [7] [8] [9] [10] [11] [12] To assess the effects of A
2677
-allele on the susceptibility, the PHASE analysis was applied, which was recently proposed novel statistical method for haplotype reconstruction from population data by Stephens et al. in 2001. 30) Current routine typical genotyping do not provide haplotype information, and it can be obtained experimentally, but at considerable cost. Alternatively, a statistical method can be used to infer phase and subsequently to reconstruct haplotype. It was found that substantial variation in the haplotype frequencies of MDR1 T-129C/C1236T/G2677A, T/C3435T ( -C 3435 were more frequently found in UC patients, 22) but this is not confirmed herein (Tables 2, 3 ). Inflammation is a complex physiological reaction to invasion by foreign substances, where soluble mediators and cellular components work synergistically in many systems. Generally, a variety of endogenous and exogenous stimuli could be involved in the molecular regulation of MDR1 expression, including cytotoxic drugs, heat shock, irradiation, inflammation, and various cytokines and growth factors. [7] [8] [9] Recently, it has been confirmed that MDR1 mRNA expression in colonic tissues is down-regulated in patients with UC, but not with CD, 18) being consistent with the finding in rats, where MDR1 is suppressed by treatment with endotoxin. 35) However, in this study, the down-regulation of MDR1 mRNA expression in the rectal mucosa of UC patients was not confirmed (Table 4) . Since the effect of C3435T is often discussed in terms of its association with expression in the tissues, [7] [8] [9] [10] [11] [12] the association of C3435T with susceptibility to later onset UC was expected to be explained by its effect on the expression; however, as shown in Table 4 , this assumption was not validated. In contrast, it was found that C3435T resulted in a higher level of expression in the early onset patients, being consistent with our previous report on the effect on duodenum in the healthy subjects.
31) It can be concluded that factors other than expression play an important role in the association of C3435T with susceptibility to UC. The effect of C3435T on the expression is important information for the pharmacotherapy of UC, 36, 37) since corticosteroids, which are often used for UC, have been reported to be substrates for MDR1, 38, 39) and MDR1 is thought to be one of the causes of corticosteroid resistance in IBDs. 40) In early onset patients, C3435T might become a reference for adjusting dosage regimens, that is, the C 3435 -noncarriers might need much greater amounts of corticosteroids, especially in case of topical use, than carriers.
In conclusion, age of onset was important for the association of C3435T with susceptibility to UC, that is, C3435T was predictive of susceptibility to later onset, whereas no such effects were found for early onset. Linkage disequilibrium of C3435T with T-129C, C1236T and G2677A, T was suggested to be altered in UC when compared with healthy subjects, but the analysis of their haplotype provided no advantage in terms of prediction over that with only C3435T. The effect of C3435T on susceptibility could not be explained by that on mRNA expression in the rectal mucosa, but it was greater in the C 3435 -noncarriers in early onset group, allowing the individualization of steroid-based pharmacotherapy.
